Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
SBFM Sunshine Biopharma
1.140-0.130-10.24%
Close
02/03 16:00 ET
1.160+0.020+1.75%
Post Mkt Price 02/03 19:59 ET
High
1.260
Open
1.230
Turnover
350.62K
Low
1.100
Pre Close
1.270
Volume
297.50K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAxcella Health (NASDAQ:AXLA) shares rose 64.0% to $0.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.8 million. Baudax Bio (NASDAQ:BXRX) stock inc
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAkanda (NASDAQ:AKAN) stock increased by 31.3% to $0.21 during Friday's pre-market session. The market value of their outstanding shares is at $7.2 million. ContraFect (NASDAQ:CFRX) shares moved
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Gainers Genius Group Limited (NYSE:GNS) rose 52.2% to $3.18 in pre-market trading. Genius Group shares jumped 290% on Thursday after the company approved a plan to create an 'Illegal Trading Task For
Top Premarket Decliners
07:49 AM EST, 01/20/2023 (MT Newswires) -- AcelRx (ACRX) shares declined 20%, adding to Thursday's losses. Panbela Therapeutics (PBLA) shares dropped 20% following a 2.4% loss in the previous session.
Sunshine Biopharma Launches $2 Million Share Buyback Program; Shares Down Pre-Bell
08:47 AM EST, 01/19/2023 (MT Newswires) -- Sunshine Biopharma (SBFM) said Thursday its board has authorized a share repurchase program for up to $2 million of its common shares. Repurchases can be ma
Sunshine Biopharma Says Board Authorized a Share-Repurchase Program for Up to $2M of Its Common Stock >SBFM
Sunshine Biopharma Announces $2M Stock Repurchase Program
Sunshine Biopharma Announces Share Repurchase Program To Acquire Up To $2M Of The Company's Common Stock
Sunshine Biopharma Announces Share Repurchase Program To Acquire Up To $2M Of The Company's Common Stock
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersORIC Pharmaceuticals (NASDAQ:ORIC) stock moved upwards by 54.3% to $4.63 during Thursday's pre-market session. The company's market cap stands at $183.2 million. IsoPlexis (NASDAQ:ISO) stock mo
Sunshine Biopharma Issues Letter to Shareholders
Company Overview
More
Sunshine Biopharma, Inc. engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. Its products include treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Pointe-Claire, Canada.
CEO： Dr. Steve N. Slilaty, PhD
Market： NASDAQ
Listing Date： 02/15/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet